Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by Hiddensecretson Jan 17, 2021 5:20pm
254 Views
Post# 32316192

RE:RE:Sanity Revenue 2021 $ 260,062,250 (QSC 28%)

RE:RE:Sanity Revenue 2021 $ 260,062,250 (QSC 28%)If we look at earnings just from Sanity, forget Collection sites it will be:  $ 39,600,000 in PROFIT
(I assume 55% profit margins)

That equates to:   .24 cents per share in EARNINGS

The virus per WHO is going to be endemic, meaning we will have it with us always, so testing will not go away.

Put a multiple of say only 5 x earnings and your arrive at $ 1.20 per share from Sanity alone.   In medical field mulitples can go as high as 30 times.  

And we have not included anything from collection sites which will be many times the 24 cents per share in earnings. 

It would seem  that a reasonable price should be over $ 10 per share at the very minimum and, at $ 20 per share I would say we are fairly valued. 

So I am thinking $ 1.7 billion to $ 3.4 billion valuation and, not $ 59 million.

And remember that MEDV will evolve as they will expand or, maybe acquire other businesses that are very lucrative.

Our CEO ran a $ 1.9 billion empire at Teva so he is no stranger to the valuations which I have posted. 

Last thing, we are going to get a CHUNK of the $ 50 billion testing announced by Biden.    Our CEO saw this 3 months in advance and made preparations for it.  See how far ahead he is of the competition.  

MPO

<< Previous
Bullboard Posts
Next >>